The use of hydroxychloroquine in patients with a history of metabolic disorders, such as diabetes or hyperlipidemia, requires careful consideration due to potential effects on glucose and lipid metabolism. <a href="
https://hcqplaquenil.com">plaquenil</a> Hydroxychloroquine has been associated with changes in glucose tolerance and lipid profiles, particularly in susceptible individuals. Healthcare providers should assess metabolic disorder risk factors and monitor glucose and lipid levels regularly in patients receiving hydroxychloroquine therapy.